Clinical trials are key to developing new drugs, medical devices, and therapies, but many never even make it off the ground. Consider the fact that 90% of new drug candidates fail and 80% of clinical trials are unable…

Bringing new drugs and compounds to market has always been expensive, but it’s become increasingly so over the last decade. Considering that up to 90% of drug candidates never make it to market, the biotech and pharma industries have…